Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
325.42
+5.17 (1.61%)
Oct 20, 2026, 4:00 PM EDT - Market closed
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $9.63 billion as of October 20, 2026. It is the 2,216th most valuable company in the world and the 784th biggest in the United States. Its market cap has increased by 74.94% in one year.
Market Cap
9.63B
Enterprise Value
8.54B
1-Year Change
74.94%
Global Rank
Country Rank
#784 United States
Category
ChartMarket Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $9.63B, an increase of 10,324.30%. That is a compound annual growth rate of 66.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 9.63B | 34.73% |
| Dec 31, 2025 | 7.15B | 58.67% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 10.58B |
| Madrigal Pharmaceuticals | 10.33B |
| Vaxcyte | 10.02B |
| Kymera Therapeutics | 8.99B |
| ImmunityBio | 8.92B |
| Twist Bioscience | 8.76B |
| Cytokinetics | 8.71B |
| Protagonist Therapeutics | 8.70B |